Seeing what Alzheimer saw

Article metrics

The ability to visualize brain pathology in living individuals with Alzheimer disease could change how the disease is diagnosed and drugs to treat it tested. A recently developed positron emission tomography tracer helps to image fibrillar amyloid-β and neurofibrillary tangles and brings us closer to this goal.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Three generations of PET studies in Alzheimer disease.

References

  1. 1

    McKhann, G. et al. Neurology 34, 939–944 (1984).

  2. 2

    Small, G.W. et al. N. Engl. J. Med. 355, 2652–2663 (2006).

  3. 3

    Braak, H. & Braak, E. Acta Neuropathol. (Berl.) 82, 239–259 (1991).

  4. 4

    Blennow, K., de Leon, M.J. & Zetterberg, H. Lancet 368, 387–403 (2006).

  5. 5

    Thal, D.R., Rub, U., Orantes, M. & Braak, H. Neurology 58, 1791–1800 (2002).

  6. 6

    Bennett, D.A. et al. Neurology 66, 1837–1844 (2006).

  7. 7

    de Leon, M.J. et al. Proc. Natl. Acad. Sci. USA 98, 10966–10971 (2001).

  8. 8

    Mosconi, L. et al. Neurobiol. Aging published online 11 January 2007 (doi:10.1016/j.neurobiolaging.2006.12.008).

  9. 9

    Rusinek, H. et al. Radiology 229, 691–696 (2003).

  10. 10

    den Heijer, T. et al. Psychiatry 63, 57–62 (2006).

  11. 11

    Buerger, K. et al. Arch. Neurol. 59, 1267–1272 (2002).

  12. 12

    Klunk, W.E. et al. Ann. Neurol. 55, 306–319 (2004).

  13. 13

    Agdeppa, E.D. et al. J. Neurosci. 21, 1–5 (2001).

  14. 14

    Powell, M.R. et al. Arch. Neurol. 63, 865–868 (2006).

  15. 15

    Logan, J. et al. J. Cereb. Blood Flow Metab. 16, 834–840 (1996).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading